XML 36 R26.htm IDEA: XBRL DOCUMENT v3.25.3
Organization (Details) - USD ($)
$ / shares in Units, $ in Thousands
May 09, 2025
May 08, 2025
Apr. 25, 2025
Sep. 30, 2025
Dec. 31, 2024
Debt Instrument [Line Items]          
Cash and cash equivalents       $ 35,652 $ 22,036
Accumulated deficit       $ (309,609) $ (294,331)
2025 Public Offering          
Debt Instrument [Line Items]          
Sale of stock, number of shares issued in transaction (in shares) 3,852,500 3,852,500      
Sale of stock (in dollars per share) $ 5.25 $ 5.25      
Proceeds from public offering, net $ 18,600 $ 18,600      
Tranche A Warrant Shares          
Debt Instrument [Line Items]          
Class of warrant or right, vested and exercisable (in shares)     400,000    
Amended Loan Agreement | Innovatus Life Sciences Lending Fund | Loan payable          
Debt Instrument [Line Items]          
Loan repayment     $ 19,700    
Perceptive Term Loan Facility | Warrant Certificate          
Debt Instrument [Line Items]          
Number of common shares to be called upon exercise of warrants (in shares)     1,150,000    
Perceptive Term Loan Facility | Tranche A Warrant Shares          
Debt Instrument [Line Items]          
Class of warrant or right, vested and exercisable (in shares)     400,000    
Perceptive Term Loan Facility | Credit Agreement Warrants          
Debt Instrument [Line Items]          
Class of warrant or right, vested and exercisable (in shares)     750,000    
Delayed Draw Term Loan | Tranche A Loan | Perceptive Credit Holdings IV, LP | Line of Credit          
Debt Instrument [Line Items]          
Proceeds from lines of credit     $ 25,000    
Delayed Draw Term Loan | Perceptive Term Loan Facility | Perceptive Credit Holdings IV, LP | Line of Credit          
Debt Instrument [Line Items]          
Proceeds from lines of credit     3,000    
Line of credit facility, maximum borrowing capacity     $ 75,000